Worldwide Internet said it has formalized a partnership agreement with SinglePoint Inc., which will provide SinglePoint access to its entire portfolio of holdings.

In addition, Green Company Holdings was recently announced as a subsidiary of Worldwide Internet that includes a diversified portfolio of investments in the hemp and medical marijuana sectors.

According to the release, Worldwide has made a sizeable investment in the subsidiary toward a diversified portfolio of cannabis-related companies and have also demonstrated interest in making direct investment into SinglePoint in light of prospects for growth

“Together SinglePoint and Green Company Holdings will begin to implement and develop premier mobile marketing and mobile payment opportunities for the medical cannabis industry via the subsidiaries,” the released stated. “In addition, the companies will work together to identify new targets for collaboration for what execs from both camps feel can lead to increased revenues and beneficial cross-marketing opportunities in the cannabis industry nationwide,” it added.

On Mar. 12, MRNA’s share value closed at 0.0043 cents, up 0.0001 cents, from its close of 0.0042 cents the previous day.

Find out what could be the best investor’s move when it comes to MRNA by getting the complete report here, or by cutting and pasting the following link in your Web browser:

http://www.sixfigurestockpicks.com

Will Develop Drugs for Rare Diseases

Meanwhile, on Mar. 12,MRNA Marina Biotech’sstock volume soared, with 772,509 shares changing hands, more than twice its three-month average volume of 328,794shares.

The surging volume is being fueled in part by the Boston, Mass. Biotech company’s Mar. 11 announcement that it plans to broadly apply its RNAi, antisense and microRNA therapeutics platform to develop drugs for rare diseases.

Besides advancing its current Phase 1 program in Familial Adenomatous Polyposis, the company expects to initially focus on the area of dystrophies where it believes its broad capabilities including its conformationally restricted nucleotide chemistry and SMARTICLES(R) delivery technology can provide an advantage over existing nucleic acid therapeutic approaches.

J. Michael French, CEO of Marina Biotech will present an overview of the company's plans today at BIO-Europe Spring 2014 in Turin, Italy.

$6 Million in Warrants

In addition, the Company announced today that it has closed its previously announced issuance of Series C Convertible Preferred Stock and common stock purchase warrants for aggregate gross proceeds to the company of $6 million

MRNA’s share value closed at $1.50, up 10 cents, from its close of $1.40 the previous day.

Find out what could be the best investor’s move when it comes to MRNA by getting the complete report here, or by cutting and pasting the following link in your Web browser:

http://www.sixfigurestockpicks.com

Easton Pharmaceuticals Reaches Agreement to Sell Hemp-Based Products

In other news, Easton Pharmaceuticals Inc. (OTCPINK: EAPH) is yet another company that has visions of selling medical marijuana products in both Canada and the United States.

On Mar.11, the Toronto-based specialty pharmaceutical company took a step toward that goal by reaching an agreement with Hemp Life Today LLC to jointly develop and distribute an exclusive line of health and beauty hemp-based products on HempLifeToday.com.

The agreement outlines that Easton Pharmaceuticals will design new and innovative hemp-based products which Hemp Life Today will market and distribute worldwide through its product website. The first hemp product to be offered on HempLifeToday.com will be Easton Pharmaceutical's newly developed Hempstral SA, an anti-aging skin moisturizer designed to combat and prevent premature aging and sun damaged skin.

Hempstral SA consists of high quality hemp oil which can now be legally obtained from US based producers and will be showcased at the Total Health Show in Toronto this April. Hempstral SA is transdermally delivered through skin tissue using Easton Pharmaceuticals' transdermal delivery matrix and formulations, which are patented or patent pending. Both companies plan to introduce other hemp-based products utilizing this technology moving forward.

On Mar.12, EAPH share price closed at 5 cents, down 1 cent from 6 cents share price at the close of the previous day.

Find out what could be the best investor’s move when it comes to EAPH by getting the complete report here, or by cutting and pasting the following link in your Web browser:

Sixfigurestockpicks.com issues momentum alerts on stocks that can provide gains to day traders.

Sixfigurestockpicks.comprovides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more.

Sixfigurestockpicks.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals DailyStockMotion.com is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the Sixfigurestockpicks.comnewsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.sixfigurestockpicks.com

Disclosure

Sixfigurestockpicks.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.